Depression News and Research

Latest Depression News and Research

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

Neuralstem, Inc. updated the progress of its ongoing Phase I human clinical trial of the company's spinal cord stem cells in the treatment of ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) at Emory University in Atlanta, Georgia.

11 Feb 2011

New model of dementia care reduces emergency department visits, hospitalizations

An innovative model of dementia care developed by researchers at the Indiana University School of Medicine and the Regenstrief Institute significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains. The result is improved health for older adults and their family caregivers and lower healthcare costs, according to a paper evaluating the model in real world use.

10 Feb 2011

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Covidien, a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for its Fentanyl Transdermal System (FTS) patch. Covidien is the largest supplier of controlled pain medications in the United States based on number of prescriptions.

10 Feb 2011

Rhabdomyolysis episode at University of Iowa signals a public health crisis

On January 26, 2011, it was reported that 13 University of Iowa football players were affected so severely by rhabdomyolysis that they were hospitalized. Occurrences of rhabdomyolysis—muscle breakdown—are so rare that it suggests an additional causal factor, such as a drug.

10 Feb 2011

Private health sector employment share in the US reaches all-time high of 10.7%

Private sector health care employment in the United States reached an all-time high of 10.7 percent of total employment, according to a report released by Altarum Institute's Center for Studying Health Spending.

10 Feb 2011

L-methylfolate in combination with antidepressant drug helps major depressive disorder patients

Data published in the January issue of Innovations in Clinical Neuroscience, www.psychiatrymmc.com, suggest when L-methylfolate, a medical food available commercially as Deplin®, and by prescription, is used for dietary management of depression in combination with an antidepressant drug at the start of depression therapy, it results in significantly more patients experiencing major improvement and more rapid improvement than antidepressant monotherapy alone.

10 Feb 2011

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

Neuralstem, Inc. announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS) with its human spinal cord derived neural stem cells (NSI-566RSC), currently in a Phase I safety study to evaluate the safety of the product and the surgical route of administration in a wide range of ALS patients.

10 Feb 2011

New study: Testosterone administration leads to significant reduction in mind reading

A new study from Utrecht and Cambridge Universities has for the first time found that an administration of testosterone under the tongue in volunteers negatively affects a person's ability to 'mind read', an indication of empathy. The findings are published this week in the journal Proceedings of the National Academy of Sciences.

9 Feb 2011

Evotec signs definitive agreement to acquire all shares in Kinaxo

Evotec AG today announced the signing of a definitive agreement to acquire all shares in Kinaxo Biotechnologies GmbH, a Munich-based drug discovery alliance company supporting the development of targeted drugs.

9 Feb 2011

Repligen third quarter total revenue increases 26% to $7,068,000

Repligen Corporation today reported results for the third quarter of fiscal year 2011, ended December 31, 2010. Total revenue for the quarter was $7,068,000 compared to total revenue of $5,617,000 for the third quarter of fiscal year 2010 ended December 31, 2009, an increase of $1,451,000 or 26%.

9 Feb 2011

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.

9 Feb 2011

AcademyHealth recognizes military health research study with 2011 HSR Impact Award

AcademyHealth today recognized research that improves access to behavioral health care for returning U.S. service members with the 2011 Health Services Research Impact Award.

9 Feb 2011

Study: Parkinson’s disease undermines language processing ability in Dutch native speaker patients

It is becoming more generally known that Parkinson's disease not only influences a patient's motor functions. Patients often also suffer from depression, fear and incontinence, for example. However, the disease also undermines the language processing ability. University of Groningen researcher Katrien Colman has found clear indications of this in Dutch native speaker patients.

9 Feb 2011

New study finds income-related inequalities impact mental health

Due to the recent economic crisis, an increase of health inequalities between socio-economic groups has been noticed in both developed and developing countries.

9 Feb 2011

Urocortin system plays central role in regulating stress responses

Post-traumatic stress disorder can affect soldiers after combat or ordinary people who have undergone harrowing experiences. Of course, feelings of anxiety are normal and even desirable - they are part of what helps us survive in a world of real threats. But no less crucial is the return to normal - the slowing of the heartbeat and relaxation of tension - after the threat has passed.

9 Feb 2011

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

Metabolon, the leader in metabolomics, biomarker discovery and analysis, announced today the grant of US Patent No. 7,884,318 entitled "Systems, Methods, and Computer-Readable Medium for Determining Composition of Chemical Constituents in a Complex Mixture".

8 Feb 2011

ADHD kids often suffer from other mental ailments: Study

As many as two thirds of American children suffering from attention-deficit/hyperactivity disorder, ADHD, also suffer other mental health and developmental conditions, such as learning disabilities and anxiety says a new study.

8 Feb 2011

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

Using a unique and relatively simple cell-based fluorescent assay they developed, scientists with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California, Berkeley have identified a means by which fluoxetine, the active ingredient in Prozac, suppresses the activity of the TREK1 potassium channel.

8 Feb 2011

Study identifies genetic variation linked with increased risk of major depression

Numerous studies have shown that the brain molecule neuropeptide Y (NPY) helps to restore calm after stressful events. A team of University of Michigan-led researchers has now found that people whose genes predispose them to produce lower levels of NPY are more responsive to negative stimuli in key brain circuits related to emotion - and are therefore less resilient in the face of stress and may be at higher risk for developing a major depressive disorder.

8 Feb 2011

NIMH awards two BUSM members with BRAINS grant for innovative research on mental disorders

Two Boston University School of Medicine faculty members, Pietro Cottone, PhD, an assistant professor of pharmacology and psychiatry and Michael Silverstein, MD, an associate professor of pediatrics, were each awarded the prestigious National Institute of Mental Health Biobehavioral Research Awards for Innovative New Scientisits grant with ten other investigators from around the country.

7 Feb 2011

Depression News and Research

Latest Depression News and Research

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

New model of dementia care reduces emergency department visits, hospitalizations

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Rhabdomyolysis episode at University of Iowa signals a public health crisis

Private health sector employment share in the US reaches all-time high of 10.7%

L-methylfolate in combination with antidepressant drug helps major depressive disorder patients

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

New study: Testosterone administration leads to significant reduction in mind reading

Evotec signs definitive agreement to acquire all shares in Kinaxo

Repligen third quarter total revenue increases 26% to $7,068,000

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

AcademyHealth recognizes military health research study with 2011 HSR Impact Award

Study: Parkinson’s disease undermines language processing ability in Dutch native speaker patients

New study finds income-related inequalities impact mental health

Urocortin system plays central role in regulating stress responses

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

ADHD kids often suffer from other mental ailments: Study

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

Study identifies genetic variation linked with increased risk of major depression

NIMH awards two BUSM members with BRAINS grant for innovative research on mental disorders

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Depression News and Research

Latest Depression News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in